TickerFacts.

Enveric Biosciences, Inc. (ENVB): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$740.3K
As of 2019-12-31
-27.5%
3-year compound annual growth
$1.94M2016-12-31: $1.94M2017-12-31: $1.88M2018-12-31: $6.5K2019-12-31: $740.3K$740.3K
2016-12-31 Long-Term Debt (USD) 2019-12-31
Period endedLong-Term DebtChange YoYSource filing
2019-12-31$740.3Kn/m2021-04-01, Balance as of period end
2018-12-31$6.5K-99.7%2019-03-26, Balance as of period end
2017-12-31$1.88M-3.2%2019-03-26, Balance as of period end
2016-12-31$1.94Mn/a2018-04-02, Balance as of period end